News & Events about Macrogenics Inc.
MacroGenics, Inc. (NASDAQ:MGNX Get Rating) major shareholder Target N. V. Biotech acquired 150,000 shares of MacroGenics stock in a transaction that occurred on Thursday, January 19th. The stock was acquired at an average price of $5.30 per share, with a total value of $795,000.00. Following...
MacroGenics, Inc. (NASDAQ:MGNX Get Rating) major shareholder Target N. V. Biotech purchased 200,000 shares of the stock in a transaction that occurred on Friday, December 23rd. The shares were purchased at an average cost of $5.88 per share, for a total transaction of $1,176,000.00. Following the ...
MacroGenics, Inc. (NASDAQ:MGNX Get Rating) has been assigned an average recommendation of Moderate Buy from the twelve research firms that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and five have given a ...
Market News Video
2 months ago
In trading on Friday, shares of MacroGenics, Inc (MGNX) crossed above their 200 day moving average of 5.88, changing hands as high as 6.15 per share. MacroGenics, Inc shares are currently trading up about 22.9% on the day...
Thinking about buying stock in MacroGenics, Anavex Life Sciences, Uber Technologies, IVERIC bio, or Roblox? Thinking about buying stock in MacroGenics, Anavex Life Sciences, Uber Technologies, IVERIC bio, or Roblox? PR Newswire NEW YORK,, Oct. 17, 2022 NEW YORK,, Oct. 17, 2022 /PRNewswire...